Graphical Abstract Highlights
Correspondence dnomura@berkeley.edu
In Brief Ford et al. show that glyphosate is metabolized to reactive metabolites that inhibit fatty acid oxidation and increase liver triglyceride and cholesteryl ester levels.
INTRODUCTION
Glyphosate, the active ingredient in Roundup, is the most commonly used pesticide in the United States across agricultural and home garden use, with 180-185 million pounds used in the United States in 2007 (Grube et al., 2011) . Glyphosate is also one of the most controversial herbicides, due to major disagreements about its safety and toxicity (Cressey, 2015; Monsanto, 2015) . Many studies have associated glyphosate exposure with various adverse health effects (El-Shenawy, 2009; Samsel and Seneff, 2015) , including cancer, liver damage, and dyslipidemia in mammals, and it was recently deemed a probable human carcinogen by the International Agency for Research on Cancer (International Agency for Research on Cancer, 2015; Portier et al., 2016) . Understanding how glyphosate interacts with biological systems in vivo in mammals is necessary to assess the prolonged effects and mechanism of toxicity of glyphosate on human health.
There have been previous efforts to characterize the toxicological mechanisms of glyphosate including acute and longterm toxicity studies in animal models, epidemiological studies in human populations, and modern systems biology approaches to map gene expression changes (Chang and Delzell, 2016; El-Shenawy, 2009; Greim et al., 2015; Mesnage et al., 2015; Portier et al., 2016; Samsel and Seneff, 2015) . However, many of these approaches have been largely correlative and have likely still missed subtler or indirect pathological effects that may arise from long-term exposures. We believe that understanding the direct chemical-protein interactions of glyphosate or its metabolites will inform our understanding of downstream molecular, metabolic, and pathophysiological effects, providing a more direct approach toward understanding toxicological mechanisms of this widely used pesticide. In this study, we have mapped glyphosate metabolism, targets, and downstream metabolic consequences in vivo in mice toward better understanding the actions of glyphosate in complex biological systems.
RESULTS AND DISCUSSION
Of concern is whether glyphosate may be biotransformed into electrophilic metabolites, which may in turn react with nucleophilic amino acid hotspots on proteins such as cysteines and lysines, which may cause disruptions in protein biochemistry, such as enzyme catalysis, post-translational regulation, redox balance, metal binding, and protein-protein interactions. Glyphosate has been reported to be metabolized by soil microbes and possibly in mammals to aminomethylphosphonic acid (AMPA) and the reactive metabolite glyoxylate (Samsel and Seneff, 2015) . Glyoxylate is an aldehyde known to react with nucleophilic amino acids on protein targets, such as cysteines, lysines, and arginines (Gohre et al., 1987; Schuette, 1998 Figure 1A ). The level of glyoxylate formed is approximately 4% of glyphosate levels detected in the liver. Glyoxylate is also produced through various metabolic pathways in mammals, such as glycine degradation (Wang et al., 2013) . We also treated mice with nonisotopic glyphosate (200 mg/kg i.p., once per day over 7 days) and show that glyphosate treatment significantly increases glyoxylate levels by 2-fold above endogenously generated levels at the doses used in this study ( Figure 1B) .
We postulated that the observed heightened levels of glyoxylate would lead to more glyoxylate reactivity with susceptible nucleophilic residues on proteins in vivo in mice ( Figure 1C ). To determine whether glyphosate metabolites formed in vivo may affect proteome reactivity, we performed a series of chemoproteomic profiling experiments using reactivity-based probes and activity-based protein profiling (ABPP), a chemoproteomic strategy that uses active-site or reactivity-based chemical probes to map reactive, functional, and ligandable hotspots directly in complex proteomes (Figure 2A ) (Counihan et al., 2015; Roberts et al., 2016) . When used in a competitive manner, reactive chemicals can be competed against reactivity-based probes to map their proteome-wide reactivity (Counihan et al., 2015; Roberts et al., 2016) . First, we performed gel-based ABPP studies in which we determined general cysteine reactivity in mice treated with vehicle or glyphosate by labeling mouse liver proteomes with the cysteine-reactive iodoacetamide-alkyne (IAyne) probe, followed by appendage of rhodamine-azide by copper-catalyzed click chemistry and in-gel fluorescence analysis. We show that in vivo glyphosate treatment selectively reduced cysteine reactivity of several protein targets in mouse liver ( Figure 2B ; Figure S1 ). To determine the identity of these targets, we next performed an ABPP proteomic experiment, in which we enriched IAynelabeled proteins from vehicle-and glyphosate-treated mouse liver proteomes through biotin-conjugation to probe-labeled proteins, avidin enrichment, and proteomic analysis. Of 340 IAyne-enriched proteins, we observed 51 protein targets that showed significantly less IAyne enrichment in glyphosate-treated mouse livers, compared with vehicle-treated controls, indicating that these targets possessed cysteines that were bound by reactive metabolites of glyphosate ( Figure 2C ; Table S1 ).
To gain an in-depth understanding of which specific cysteines on proteins were particularly susceptible to in vivo reactive glyphosate and glyphosate metabolites in mouse liver 
Glyphosate metabolites of glyphosate, we performed isotopic tandem orthogonal proteolysis-enabled ABPP (isoTOP-ABPP) to map proteome-wide cysteine reactivity of glyphosate and its metabolites in vivo in mouse liver (Weerapana et al., 2010) (Figure 2A ). We labeled in vivo vehicle-and glyphosate-treated mouse liver proteomes with IAyne, followed by linking an isotopically light (vehicle) or heavy (glyphosate-treated) tobacco etch virus (TEV) recognition site-bearing biotin handle by click chemistry, combining the vehicle and glyphosate proteomes together in a 1:1 ratio, enriching IAyne-labeled proteins by biotin pulldown, tryptically digesting enriched proteins, and subsequently releasing the probe-modified tryptic peptides by TEV protease digestion. We identified >3,500 peptides bearing light or heavy IAyne-modified cysteines (Table S1 ). We quantitatively compared and interpreted only those peptides that were found in at least two of the three biological replicates. Among these resulting 320 cysteine-modified peptides, 190 showed >1.5, 67 showed >2, and 20 showed >3 light to heavy ratios (Figures 2D and 3A ; Table  S1 ). To determine whether these changes in ratios were dependent on changes in protein expression, we also performed standard proteomic profiling of vehicle-and glyphosate-treated liver proteomes. While 2810007J24Rik and Selenbp2 protein expression was significantly lower in glyphosate-treated mouse livers, we show that most of the protein targets that showed >3 light to heavy ratios did not show reduced protein expression, indicating that these targets are likely to be direct targets of glyphosate metabolites (Table S1 ). Among the top 21 modified peptides showing >3 light to heavy ratios, two of these cysteines corresponded to an annotated catalytic cysteine on Acaa1b (C123) and Aldh9a1 (C312) and one of these cysteines is an annotated glutathionylated site (C69) on Fabp1 (highlighted in red in Figure 3A) , indicating that the function of these enzymes may be impaired by glyphosate or its metabolites in vivo (Chevillard et al., 2004; Dö rmann et al., 1993; Riveros-Rosas et al., 2013) . Acaa1b is a thiolase involved in peroxisomal fatty acid oxidation (Chevillard et al., 2004; Fidaleo et al., 2011) . Aldh9a1 is an aldehyde dehydrogenase involved in the dehydrogenation of g-aminobutyraldehyde to the neurotransmitter g-aminobutyric acid (Lin et al., 1996) . Fabp1 is a cytosolic fatty acid-binding protein involved in fatty acid transport and is a central regulator of whole-body metabolic control (Thumser et al., 2014) . We also mapped lysine reactivity using the previously described dichlorotriazine-alkyne (DCTyne) probe (Shannon et al., 2014) . In mapping lysine reactivity with isoTOP-ABPP methods, we also identified three additional lysines annotated as known succinylation or acetylation sites on Hsd17b10 (K222), Cps1 (K1269), and Hbb-b1 (K145) that also showed light to heavy ratios >3 ( Figure S2 ).
Mining deeper into our isoTOP-ABPP data, we also noticed that the peptides bearing catalytic cysteines for several thiolase family members also showed light to heavy ratios >1.5, including C92 of the mitochondrial fatty acid oxidation enzyme Acaa2, C94 of the peroxisomal fatty acid oxidation enzyme Scp2, and C92 of the cytosolic acetyl CoA acetyltransferase (Acat2) involved in biosynthesis of ketone bodies such as acetoacetyl-CoA (Figure 3B) . As Acaa2, Acat2, and Scp2 protein expression was not significantly reduced upon glyphosate treatment (Table  S1 ), we interpret these data to indicate that these cysteines are directly modified by glyphosate metabolites. We further show that glyoxylate displaces IAyne labeling of pure Acaa1b, Acaa2, and Scp2 in vitro and that glyoxylate also inhibits thiolase activities of Acaa1b and Acaa2 ( Figures 3C and 3D ). In addition, we performed isoTOP-ABPP analysis on in vitro glyoxylate cysteine reactivity in mouse liver proteomes and show that glyoxylate shows very similar reactivity signatures to those observed with in vivo glyphosate treatment, where we show that 141 of the 190 in vivo targets of glyphosate (74%) show >1.5 light to heavy ratios. This signature includes Acaa1b, Acaa2, and Scp2, which show >1.5 light to heavy ratios for nearly every probe-labeled site on these proteins for both in vitro glyoxylate and in vivo glyphosate treatments ( Figure S3 ; Table S1 ).
Interestingly, Acaa1b, Acaa2, and Scp2 are all involved in mitochondrial or peroxisomal oxidation of long-chain and branched-chain fatty acids (Haapalainen et al., 2006) . Genetic deficiencies in these thiolases or in peroxisomal or mitochondrial fatty acid oxidation pathways have been shown to cause liver dysfunction; lipid dysregulation in the form of elevated triacylglycerols, ceramides, and sterols; and hepatic steatosis, likely because the fatty acids that are not oxidized are diverted into other lipid metabolism pathways (Kim et al., 2014; Klipsic et al., 2015; Lee et al., 2016; Mizuno et al., 2013; Wanders et al., 2015) .
We hypothesized that labeling of the catalytic cysteines on several thiolases involved in fatty acid oxidation would lead to the inhibition of these targets, impaired fatty acid oxidation, and diversion of fatty acids into other lipid pathways, including A) Work flow for isoTOP-ABPP analysis. Mice were treated with glyphosate (200 mg/kg i.p., once per day for 7 days), and liver proteomes were treated with IAyne (100 mM) ex vivo, followed by click-chemistry-mediated appendage of a biotin tag bearing a TEV protease cleavage sequence and an isotopically light or heavy valine. Proteomes were combined, avidin enriched, and tryptically digested, and modified peptides were isolated by TEV digestion followed by quantitative proteomic analysis. (B) Gel-based ABPP analysis of cysteine-reactivity profiling of liver proteomes from mice treated in vivo with vehicle or glyphosate. Proteomes were labeled with IAyne followed by click-chemistry-mediated appendage of rhodamine-azide or biotin-azide, followed by in-gel fluorescence or avidin enrichment and proteomic analysis. Arrows are pointing to IAyne-labeled bands that are lighter in glyphosate-treated groups. Shown are a representative gel and a heatmap showing IAyneenriched protein targets, where dark blue indicates relative protein expression in control compared with that of glyphosate-treated mice. Light blue or white indicates proteins that showed reduced IAyne enrichment. (C) Proteins that showed significantly (p < 0.05) reduced IAyne enrichment in livers from glyphosate-treated mice compared with vehicle-treated controls. (D) isoTOP-ABPP analysis of IAyne-labeled peptides from vehicle-treated (light) and glyphosate-treated (heavy) mouse livers. Protein names for peptides showing light to heavy ratio >3 are designated. Data in (C) are presented as means ± SEM, n = 3 mice/group. Iodoacetamide-rhodamine labeling data are shown in Figure S1 . Protein expression profiling data are shown in Table S1 . Lysine-reactivity data are shown in Figure S2 . Raw and analyzed data from (B)-(D) can be found in Table S1 . Figure 1 is related to Figures  S1 and S2 and Table S1 . (legend continued on next page) triglycerides, sterols, and ceramides. We next performed a lipidomic profiling experiment in which we quantitatively measured the levels of 192 lipid and sterol species in vehicle-compared with glyphosate-treated mouse livers. We identified 62 distinct lipid species whose levels were significantly altered upon glyphosate treatment ( Figure 3E ; Table S2 ). These changes included elevations in several neutral lipids, including monoacylglycerols (MAGs), diacylglycerols (DAGs), and triacylglycerols (TAGs). We also observed increases in cholesterol and cholesteryl oleate levels as well as other lipid classes. Our data reveal that glyphosate treatment at high doses causes major lipid dysregulation, including increases in fat storage and cholesteryl esters in mouse liver ( Figure 3E , Table S2 ). To further confirm our hypothesis, we also treated HEPG2 hepatocytes with glyoxylate and traced the fate of exogenously added isotopically labeled [ Figure 3F ). These data are all consistent with our premise that inhibition of fatty acid oxidation enzymes by the glyphosate metabolite glyoxylate is associated with diversion of fatty acids into other lipid metabolism pathways. We show here using both chemoproteomic and metabolomics approaches that glyphosate may be metabolized to reactive metabolites such as glyoxylate, which may react with and inhibit many cysteine-reactive protein targets in vivo in mouse liver, including several fatty acid oxidation enzymes, which may be associated with elevations in liver triacylglycerols, cholesteryl esters, and other lipid species ( Figure 3G ). We caution that the doses used in this study are much higher than any exposure levels encountered by the public and that further studies using lower doses in more relevant exposure paradigms will be necessary to fully evaluate these findings. Our data nonetheless show that glyphosate may be biotransformed to reactive metabolites that broadly react with key cysteines and lysines across many proteins in vivo, several of which are likely to cause dysfunction of those proteins and downstream physiological effects. Furthermore, while we identify glyoxylate as one possible metabolite of glyphosate that could be reactive, there may be additional reactive metabolites, which may explain the reactivity profiles observed in this study (Gohre et al., 1987) . We also do not yet understand the tissues, cell types, and enzymes responsible for glyphosate metabolism and we cannot necessarily rule out the gut microbiome as a source for glyphosate metabolism into glyoxylate.
Nonetheless, our study provides much-needed mechanistic insights into the potential toxicities and toxicological mechanisms associated with glyphosate. Our data here show that in vivo glyphosate exposure may lead to generation of reactive metabolites such as glyoxylate, which may in turn inhibit fatty acid oxidation enzymes. We also show that glyphosate treatment at high doses is associated with heightened levels of triglycerides and cholesteryl esters and may potentially lead to corresponding metabolic disorders. Our results highlight the utility of using chemoproteomic platforms such as ABPP to map the proteome-wide reactivity and targets of environmental chemicals toward understanding their mechanisms of toxicity.
SIGNIFICANCE
In this study, we have used chemoproteomic and metabolomic platforms to map the direct targets and downstream metabolic consequences of glyphosate and its metabolites in vivo in mice, toward better understanding the potential toxicological mechanisms of this active ingredient found in the very widely used herbicide Roundup. We show that glyphosate is metabolized in vivo to a reactive metabolite, glyoxylate, at high doses in mice, where it reacts with many protein targets. We show that fatty acid oxidation enzymes are inhibited by glyoxylate and that glyphosate treatment in mice leads to elevated levels of fat and cholesteryl esters in the liver.
EXPERIMENTAL PROCEDURES
Mice Male C57BL/6 mice (6-8 weeks old) were acutely (2 hr) or subacutely (7 days) exposed by i.p. injection to 200 mg/kg glyphosate (Sigma 45521) in a vehicle of PBS (10 mL/g mouse weight). Following exposure, mice were sacrificed by cervical dislocation, and liver and serum were immediately removed and flash frozen in liquid nitrogen. Animal experiments were conducted in accordance with the guidelines of the Institutional Animal Care and Use Committee of the University of California, Berkeley.
Processing of Mouse Liver Proteomes
Tissues were homogenized in PBS, followed by a 1,000 3 g centrifugation of the homogenate. The resulting supernatant was collected and used for subsequent assays. Protein concentrations were determined by BCA protein assay (Pierce).
Activity Assays
Enzymatic activity of Acaa1b and Acaa2 was performed using the Fluorometric Acetyltransferase Activity Assay Kit (Abcam ab204536). The assay was performed per the protocol with 0.4 mg of pure protein, 3 mM glyoxylate, and 100 nM acetoacetyl-CoA (Sigma A1625); fluorescence was measured at 380/520 ex/em on a SpectraMax i3x detection platform.
Proteomic Analysis
For ABPP and isoTOP-ABPP analysis, we performed studies as previously described (Medina-Cleghorn et al., 2015; Weerapana et al., 2010) . Detailed procedures are described in the Supplemental Experimental Procedures. Isotopically labeled triglycerides were measured using SRM-based LC-MS/MS. (G) Diagram showing how glyphosate metabolites inhibit thiolases involved in peroxisomal and mitochondrial fatty acid oxidation, leading to accumulation of fatty acids in other lipid and sterol species. Glyoxylate cysteine-reactivity data are shown in Figure S3 and Table S1 . Data in (E and F) are presented as the mean ± SEM, n = 5/group. Significance in (F) is presented as *p < 0.05 compared with vehicle-treated control.
Metabolomic Profiling
Metabolomic profiling was performed as previously described (Benjamin et al., 2013; Louie et al., 2016 
